CST3 and kidney disorder: The prognostic role of SELENOP for SGHS and kidney-related hospitalization in HF remains unclear.<h4>Purpose</h4>To assess whether SELENOP is associated with SGHS at baseline and future kidney disease hospitalization in acute HF patients.<h4>Methods</h4>In 570 patients hospitalized for acute HF, creatinine and cystatin C were analyzed; SELENOP was measured in the first 320 using an immunoassay.